Primary mast cell disorders in children

Current Allergy and Asthma Reports

Volumn 13, Issue 6, 2013, Pages 693-701

  Fried, Ari J ^a   Akin, Cem ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Children; Classification; Cutaneous mastocytosis; Diagnosis; Diffuse cutaneous mastocytosis; Kit; Mast cell disorders; Mast cell mediator symptoms; Mastocytosis; Pathogenesis; Pediatric; Pediatric mastocytosis; Solitary mastocytoma; Treatment; Urticaria pigmentosa

Indexed keywords

ADRENALIN; CROMOGLYCATE DISODIUM; GLUCOCORTICOID; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PSORALEN; STEM CELL FACTOR RECEPTOR; TRYPTASE;

ANAPHYLAXIS; ARTICLE; BONE MARROW BIOPSY; CANCER SURGERY; CLINICAL FEATURE; DISEASE CLASSIFICATION; ENZYME BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; GENE MUTATION; HUMAN; IMMUNOPATHOLOGY; MAST CELL DEGRANULATION; MAST CELL DISORDER; MASTOCYTOMA; MASTOCYTOSIS; PALLIATIVE THERAPY; PATHOGENESIS; PERIOPERATIVE PERIOD; PHOTOTHERAPY; PHYSICAL EXAMINATION; PUVA; SKIN BIOPSY; SYMPTOM; SYSTEMIC MASTOCYTOSIS; URTICARIA PIGMENTOSA;

BIOPSY; CHILD; DISEASE PROGRESSION; HUMANS; MAST CELLS; MASTOCYTOSIS; QUALITY OF LIFE;

EID: 84890562829     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-013-0392-6     Document Type: Article

References (49)

1. Akin C, Valent P, Metcalfe DD. Mast cell activation syndrome: proposed diagnostic criteria. J Allergy Clin Immunol. 2010;126(6):1099-104.e4.
2. Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997;90(4):1345-64.
3. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A. 1995;92(23):10560-4.
4. Longley Jr BJ, Metcalfe DD, Tharp M, Wang X, Tyrrell L, Lu SZ, et al. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A. 1999;96(4):1609-14.
5. Akin C. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn. 2006;8(4):412-9.
6. Kitamura Y. Gastrointestinal stromal tumors: past, present, and future. J Gastroenterol. 2008;43(7):499-508.
7. Zanotti R, Simioni L, Garcia-Montero AC, Perbellini O, Bonadonna P, Caruso B, et al. Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. J Allergy Clin Immunol. 2013;131(2):605-7.
8. Broesby-Olsen S, Kristensen TK, Møller MB, Bindslev-Jensen C, Vestergaard H. Mastocytosis Centre, Odense University Hospital (MastOUH). Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations. J Allergy Clin Immunol. 2012;130(3):806-8.
9. Büttner C, Henz BM, Welker P, Sepp NT, Grabbe J. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Investig Dermatol. 1998;111(6):1227-31.
10. Yanagihori H, Oyama N, Nakamura K, Kaneko F. c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation. J Mol Diagn. 2005;7(2):252-7.
11. Verzijl A, Heide R, Oranje AP, van Schaik RH. C-kit Asp-816-Val mutation analysis in patients with mastocytosis. Dermatology. 2007;214(1):15-20.
12. Bodemer C, Hermine O, Palmérini F, Yang Y, Grandpeix-Guyodo C, Leventhal PS, et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Investig Dermatol. 2010;130(3):804-15. This work describes the association of childhood cutaneous mastocytosis with c-kit mutations in a patient cohort. The authors detected c-kit mutations in the majority of children examined, including mutations within and outside of the tyrosine kinase domain.
13. Sotlar K, Escribano L, Landt O, Möhrle S, Herrero S, Torrelo A, et al. One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol. 2003;162(3):737-46.
14. Escribano L, Alvarez-Twose I, Sánchez-Muñoz L, Garcia-Montero A, Núñez R, Almeida J, et al. Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol. 2009;124(3):514-21.
15. Schwaab J, Schnittger S, Sotlar K, Walz C, Fabarius A, Pfirrmann M, Kohlmann A, Grossmann V, Meggendorfer M, Horny HP, Valent P, Jawhar M, Teichmann M, Metzgeroth G, Erben P, Ernst T, Hochhaus A, Haferlach T, Hofmann WK, Cross NC, Reiter A. Comprehensive mutational profiling in advanced systemic mastocytosis. Blood. 2013;122(14):2460-6.
16. Nettleship E, Tay W. Rare forms of urticaria. Br Med J. 1869;2:323.
17. Unna PG. Bëitrage Zur Anatomic und Pathogenese der Urticaria Simplex und Pigmentosa. Mschr Prakt Dermatol, Suppl Dermatol Stud. 1887;3:9.
18. Sangster A. An anomalous mottled rash, accompanied by pruritis, factious urticaria and pigmentation, "urticaria pigmentosa (?). Trans Clin Soc Lond. 1878;11:161.
19. Ellis JM. Urticaria pigmentosa: a report of a case with autopsy. Arch Pathol. 1949;48:426.
20. Valent P, Horny H, Longley BJ, et al. Mastocytosis. In: Jaffe ES, Harris NL, Stein H, Varderman JE, editors. World Health Organization Classification of Tumors: Pathology and Genetics in Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001. p. 291-302.
21. Caplan RM. The natural course of urticaria pigmentosa: analysis and follow-up of 112 cases. Arch Dermatol. 1963;87:146.
22. Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis: a review of 180 patients. Isr Med Assoc J. 2005;7(5):320-2.
23. Soter NA. The skin in mastocytosis. J Investig Dermatol. 1991;96(3 Suppl):32S-8S.
24. Hartmann K, Henz BM. Classification of cutaneous mastocytosis: a modified consensus proposal. Leuk Res. 2002;26(5):483-4.
25. Robinson HM, Kile RL, Hitch JM, Robinson RC. Bullous urticardia pigmentosa. Arch Dermatol. 1962;85:346-57.
26. Brockow K, Akin C, Huber M, et al. Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology. J Am Acad Dermatol. 2003;48(4):508-16.
27. Ryan RJ, Akin C, Castells M, Wills M, Selig MK, Nielsen GP, et al. Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications. Mod Pathol. 2013;26(4):533-43.
28. Heide R, Zuidema E, Beishuizen A, Den Hollander JC, Van Gysel D, Seyger MM, et al. Clinical aspects of diffuse cutaneous mastocytosis in children: two variants. Dermatology. 2009;219(4):309-15.
29. Lange M, Niedoszytko M, Nedoszytko B, Łata J, Trzeciak M, Biernat W. Diffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature. J Eur Acad Dermatol Venereol. 2012;26(12):1565-71.
30. Walker T, von Komorowski G, Scheurlen W, Dorn-Beineke A, Back W, Bayerl C. Neonatal mastocytosis with pachydermic bullous skin without c-Kit 816 mutation. Dermatology. 2006;212(1):70-2.
31. Hannaford R, Rogers M. Presentation of cutaneous mastocytosis in 173 children. Australas J Dermatol. 2001;42(1):15-21.
32. Uzzaman A, Maric I, Noel P, Kettelhut BV, Metcalfe DD, Carter MC. Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology. Pediatr Blood Cancer. 2009;53(4):629-34.
33. Alvarez-Twose I, Vañó-Galván S, Sánchez- Muñoz L, Morgado JM, Matito A, Torrelo A, et al. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy. 2012;67(6):813-21. In this study the authors describe the correlation of basal serum tryptase levels with extent and severity of mast cell disease. The work highlights that there is a large spectrum of disease involvement and severity, and shows the value of measurement of serum tryptase levels in the evaluation of patients.
34. Akin C, Fumo G, Yavuz AS, Lipsky PE, Neckers L, Metcalfe DD. A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood. 2004;103(8):3222-5.
35. Castells M, Metcalfe DD, Escribano L. Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations. Am J Clin Dermatol. 2011;12(4):259-70.
36. Murphy M, Walsh D, Drumm B, Watson R. Bullous mastocytosis: a fatal outcome. Pediatr Dermatol. 1999;16(6):452-5.
37. Azana JM, Torrelo A, Mediero IG, et al. Urticaria pigmentosa: a review of 67 pediatric cases. Pediatr Dermatol. 1994;11(2):102-6.
38. Akoglu G, Erkin G, Cakir B, et al. Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients. J Eur Acad Dermatol Venereol. 2006;20(8):969-73.
39. Komarow HD, Hu Z, Brittain E, Uzzaman A, Gaskins D, Metcalfe DD. Serum tryptase levels in atopic and nonatopic children. J Allergy Clin Immunol. 2009;124(4):845-8.
40. Carter MC, Metcalfe DD. Paediatric mastocytosis. Arch Dis Child. 2002;86(5):315-9.
41. Akin C, Valent P, Escribano L. Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment. Curr Allergy Asthma Rep. 2006;6(4):282-8.
42. Wolff K. Treatment of cutaneous mastocytosis. Int Arch Allergy Immunol. 2002;127(2):156-9.
43. Mackey S, Pride HB, Tyler WB. Diffuse cutaneous mastocytosis. Treatment with oral psoralen plus UV-A. Arch Dermatol. 1996;132(12):1429-30.
44. Stern RS. Psoralen and ultraviolet a light therapy for psoriasis. N Engl J Med. 2007;357(7):682-90.
45. Alvarez-Twose I, González P, Morgado JM, Jara-Acevedo M, Sánchez-Muñoz L, Matito A, et al. Complete response after imatinib mesylate therapy in a patient with well-differentiated systemic mastocytosis. J Clin Oncol. 2012;30(12):e126-9.
46. Vaughan ST, Jones GN. Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia. Anaesthesia. 1998;53(8):804-7.
47. Carter MC, Uzzaman A, Scott LM, et al. Pediatric mastocytosis: routine anesthetic management for a complex disease. Anesth Analg. 2008;107(2):422-7.
48. Ahmad N, Evans P, Lloyd-Thomas AR. Anesthesia in children with mastocytosis - a case based review. Paediatr Anaesth. 2009;19(2):97-107.
49. Tirel O, Chaumont A, Ecoffey C. Circulatory arrest in the course of anesthesia for a child with mastocytosis. Ann Fr Anesth Reanim. 2001;20(10):874-5.